Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features - 11/11/23
, Archana Singal, MD dAbstract |
Tuberculosis is an ancient disease that continues to affect an estimated 10 million people per year and is responsible for 1.4 million deaths per year. Additionally, the HIV epidemic and multidrug resistance present challenges to disease control. Cutaneous tuberculosis is an uncommon, often indolent, manifestation of mycobacterial infection that has a varied presentation. Its diagnosis is challenging, as lesions mimic other, more common conditions and microbiological confirmation is often not possible. Cutaneous tuberculosis can be broadly categorized into multibacillary and paucibacillary forms. Approximately one-third of skin tuberculosis is associated with systemic involvement. By recognizing cutaneous tuberculosis early, dermatologists can play an important role in disease control. The first article in this 2-part continuing medical education series describes the latest epidemiology, microbiology, and pathogenesis of tuberculosis. Furthermore, we review the classification, clinical manifestations, common clinical differentials, and systemic involvement that occur in cutaneous tuberculosis.
Le texte complet de cet article est disponible en PDF.Key words : BCG, cutaneous, erythema induratum, lichen scrofulosorum, lupus vulgaris, mycobacterium, papulonecrotic tuberculid, scrofuloderma, skin, tuberculid, tuberculosis
Abbreviations used : BCG, CTB, IFN, IL, LV, MTB, TB, TBVC, TLR
Plan
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Date of release: December 2023. |
|
| Expiration date: December 2026. |
|
| Reprints not available from the authors. |
Vol 89 - N° 6
P. 1091-1103 - décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
